Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101)

Clinical trial NCT05090280 · COMPLETED

Trial details

NCT number: NCT05090280
Sponsor: Ensysce Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2021-12-01
Primary completion: 2023-04-26
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.